Gastrointestinal Dysfunction in Parkinson’s Disease

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Purpose of review: During the past 25 years, there has been an explosion of information regarding the occurrence of gastrointestinal dysfunction in Parkinson’s disease. In this review, the clinical features of gastrointestinal dysfunction in Parkinson’s disease will be described and information regarding the potential role of the enteric nervous system and the gut microbiome in the genesis of Parkinson’s disease will be addressed. Recent findings: Recognition is growing regarding the role that gastroparesis and small intestinal dysfunction may play in Parkinson’s disease, especially with regard to erratic responses to anti-Parkinson medication. The presence of enteric nervous system involvement in Parkinson’s disease is now well established, but whether the enteric nervous system is the starting point for Parkinson’s disease pathology remains a source of debate. The potential role of the gut microbiome also is beginning to emerge. Summary: Gastrointestinal dysfunction is a prominent nonmotor feature of Parkinson’s disease and dysfunction can be found along the entire length of the gastrointestinal tract. The enteric nervous system is clearly involved in Parkinson’s disease. Whether it is the initial source of pathology is still a source of controversy. There also is growing recognition of the role that the gut microbiome may play in Parkinson’s disease, but much more research is needed to fully assess this aspect of the disorder.

Original languageEnglish (US)
Article number54
JournalCurrent Treatment Options in Neurology
Volume20
Issue number12
DOIs
StatePublished - Dec 1 2018

Fingerprint

Parkinson Disease
Enteric Nervous System
Pathology
Gastroparesis
Explosions
Gastrointestinal Tract
Research
Gastrointestinal Microbiome

Keywords

  • Alpha-synuclein
  • Constipation
  • Dysphagia
  • Enteric
  • Gastrointestinal
  • Gastroparesis
  • Microbiome
  • Vagus

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Gastrointestinal Dysfunction in Parkinson’s Disease. / Pfeiffer, Ronald.

In: Current Treatment Options in Neurology, Vol. 20, No. 12, 54, 01.12.2018.

Research output: Contribution to journalReview article

@article{0c811594edab4334b869bd8663c33ce5,
title = "Gastrointestinal Dysfunction in Parkinson’s Disease",
abstract = "Purpose of review: During the past 25 years, there has been an explosion of information regarding the occurrence of gastrointestinal dysfunction in Parkinson’s disease. In this review, the clinical features of gastrointestinal dysfunction in Parkinson’s disease will be described and information regarding the potential role of the enteric nervous system and the gut microbiome in the genesis of Parkinson’s disease will be addressed. Recent findings: Recognition is growing regarding the role that gastroparesis and small intestinal dysfunction may play in Parkinson’s disease, especially with regard to erratic responses to anti-Parkinson medication. The presence of enteric nervous system involvement in Parkinson’s disease is now well established, but whether the enteric nervous system is the starting point for Parkinson’s disease pathology remains a source of debate. The potential role of the gut microbiome also is beginning to emerge. Summary: Gastrointestinal dysfunction is a prominent nonmotor feature of Parkinson’s disease and dysfunction can be found along the entire length of the gastrointestinal tract. The enteric nervous system is clearly involved in Parkinson’s disease. Whether it is the initial source of pathology is still a source of controversy. There also is growing recognition of the role that the gut microbiome may play in Parkinson’s disease, but much more research is needed to fully assess this aspect of the disorder.",
keywords = "Alpha-synuclein, Constipation, Dysphagia, Enteric, Gastrointestinal, Gastroparesis, Microbiome, Vagus",
author = "Ronald Pfeiffer",
year = "2018",
month = "12",
day = "1",
doi = "10.1007/s11940-018-0539-9",
language = "English (US)",
volume = "20",
journal = "Current Treatment Options in Neurology",
issn = "1092-8480",
publisher = "Current Science, Inc.",
number = "12",

}

TY - JOUR

T1 - Gastrointestinal Dysfunction in Parkinson’s Disease

AU - Pfeiffer, Ronald

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Purpose of review: During the past 25 years, there has been an explosion of information regarding the occurrence of gastrointestinal dysfunction in Parkinson’s disease. In this review, the clinical features of gastrointestinal dysfunction in Parkinson’s disease will be described and information regarding the potential role of the enteric nervous system and the gut microbiome in the genesis of Parkinson’s disease will be addressed. Recent findings: Recognition is growing regarding the role that gastroparesis and small intestinal dysfunction may play in Parkinson’s disease, especially with regard to erratic responses to anti-Parkinson medication. The presence of enteric nervous system involvement in Parkinson’s disease is now well established, but whether the enteric nervous system is the starting point for Parkinson’s disease pathology remains a source of debate. The potential role of the gut microbiome also is beginning to emerge. Summary: Gastrointestinal dysfunction is a prominent nonmotor feature of Parkinson’s disease and dysfunction can be found along the entire length of the gastrointestinal tract. The enteric nervous system is clearly involved in Parkinson’s disease. Whether it is the initial source of pathology is still a source of controversy. There also is growing recognition of the role that the gut microbiome may play in Parkinson’s disease, but much more research is needed to fully assess this aspect of the disorder.

AB - Purpose of review: During the past 25 years, there has been an explosion of information regarding the occurrence of gastrointestinal dysfunction in Parkinson’s disease. In this review, the clinical features of gastrointestinal dysfunction in Parkinson’s disease will be described and information regarding the potential role of the enteric nervous system and the gut microbiome in the genesis of Parkinson’s disease will be addressed. Recent findings: Recognition is growing regarding the role that gastroparesis and small intestinal dysfunction may play in Parkinson’s disease, especially with regard to erratic responses to anti-Parkinson medication. The presence of enteric nervous system involvement in Parkinson’s disease is now well established, but whether the enteric nervous system is the starting point for Parkinson’s disease pathology remains a source of debate. The potential role of the gut microbiome also is beginning to emerge. Summary: Gastrointestinal dysfunction is a prominent nonmotor feature of Parkinson’s disease and dysfunction can be found along the entire length of the gastrointestinal tract. The enteric nervous system is clearly involved in Parkinson’s disease. Whether it is the initial source of pathology is still a source of controversy. There also is growing recognition of the role that the gut microbiome may play in Parkinson’s disease, but much more research is needed to fully assess this aspect of the disorder.

KW - Alpha-synuclein

KW - Constipation

KW - Dysphagia

KW - Enteric

KW - Gastrointestinal

KW - Gastroparesis

KW - Microbiome

KW - Vagus

UR - http://www.scopus.com/inward/record.url?scp=85055444253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055444253&partnerID=8YFLogxK

U2 - 10.1007/s11940-018-0539-9

DO - 10.1007/s11940-018-0539-9

M3 - Review article

AN - SCOPUS:85055444253

VL - 20

JO - Current Treatment Options in Neurology

JF - Current Treatment Options in Neurology

SN - 1092-8480

IS - 12

M1 - 54

ER -